Cardiologists Conferences 2018| Cardiology Conferences | Cardiology Meetings | Cardiology Events | Asia Pacific | Europe | USA | Middle East | 2018

Theme: Novel Technologies and Innovations in Cardiovascular Care

Cardiologists Congress 2018

Scientific Program (2018)

Renowned Speakers

Roland Hetzer
Former Medical Director German Heart Center Berlin,
Germany

Amir Landesberg
Former Dean, Faculty of Biomedical Engineering Technion,
Israel

Sibel Catirli Enar
Associate Professor Sisli Memorial Hospital Istanbul,
Turkey

Sebastian Schaefer
Assistant Professor, Duke-NUS Medical School and the National Heart Centre
Singapore

Ali Al-Fiadh
Consultant Interventional Cardiologist at Austin Health,
Australia

Malcolm Underwood
Professor Chinese University of Hong Kong.
Hong Kong

Swati Mukherjee
Interventional Cardiologist, Monash University,
Australia

Maxima Mendez
Cardiologist- Lipid Master
Dominican Republic

Hidemasa Shitan
Cardiologist
Japan

Cardiologists Congress 2018

Conference Series llc LTD takes a pleasure by cheerfully welcomes you all for the “25th Annual Cardiologists conference” during Sep 17-18, 2018, Hongkong. This event will bring together world-class professors, renowned scientists and best cardiologists to discuss about Clinical Cardiology, interventional cardiology, Heart diseases, Echocardiogram/Echocardiography, Three-dimensional echocardiography, Pediatric cardiology, Nuclear Cardiology, Intravascular Ultrasound. Cardiologist’s conference provides a platform for a wide exchange of knowledge that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease. The conference will be organized with the theme of “Novel Technologies and Innovations in Cardiovascular Care”

Ultimate aim of this conference is to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical professionals like Directors, Heads, Deans, Professors, Scientists, Researchers, Cardiologists, Cardiothoracic Surgeons, Cardiac Nurses, Founders and Employees of the related companies, Associations, Organizations, Laboratory members and Young researchers working in the field of cardiology and related fields. This conference mainly focuses on spreading the awareness about challenges in this fields and how to prevent and manage the techniques of cardiology.

Conference Series llc LTD Organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma, cardiology diagnosis workshops, cardiac nursing conferences, cardiac conferences and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend??

Encounter the target market with members from across the globe, committed to learn about novel technologies and innovations in Cardiovascular Care. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the advancements in Clinical Cardiology, Cardiac Imaging, Cardiac Regeneration and in different fields of cardiology by receiving name recognition at this 2-days event. World-eminent speakers, most recent researches, latest treatment techniques and the advanced updates in Cardiology are the principal features of this conference.

Target Audience:

Our Organization would be privileged to welcome the:

Directors of Clinical cardiology, Interventional Cardiology, Nuclear Cardiology, Pediatric Cardiology, Sports Cardiology or related Programs or Associations
Heads, Deans and Professors of Clinical cardiology, Interventional Cardiology, Nuclear Cardiology, Pediatric Cardiology, Sports Cardiology and related departments
Scientists and Researchers
Doctors
Writers
Founders and Employees of the related companies
Clinical cardiology, Interventional Cardiology, Nuclear Cardiology, Pediatric Cardiology, Sports Cardiology Associations and Organizations
Laboratory members and Students working in the field of Nuclear Cardiology

Track 1: Cardiologists

Cardiologists are the doctors who are specialized in the field of diagnosing and treating the diseases of heart and heart abnormalities. Besides these, they are also concerned with the circulatory system, including arteries and veins. They are also called specialty of internal medicine. Cardiology is the rapidly growing and changing field, where we can see the day-to-day developments in cardiology related techniques. New technologies such as drug-eluting stents assist devices for left ventricle, and novel inflammatory markers, and imaging modalities includes magnetic resonance imaging and 3D echocardiography provides an unprecedented view of the function of the heart in health and an unparalleled prospect of therapies with which to treat disease.

2^nd International Conference on Non-invasive, Cardiac Imaging, nuclear Cardiology & Echocardiography, September 11-13, 2017. Amsterdam, Netherlands; 2^nd International Conference on Hypertension& Healthcare September 11-13, 2017. Amsterdam, Netherlands; 20^th European Cardiology Conference, October 16-18, 2017, 3rd Global Summits on Heart Diseases, November 02-04, 2017, 21^st International Conference On Clinical & Experimental Cardiology, November 06-07,2017,LAS VEGAS,USA;22^nd World Cardiology Conference, December 11-12, 2017; 23^rd European Heart Disease And Heart Failure Congress, February 19-21, 2018; 23^rd World cardiology Conference, March 19-20,2018; 2^nd World Heart Congress, May 14-16,2018; Global Cardiology Summit, August 15-16,2018, Tokyo, Japan; International Conference on Cardiovascular Imaging, November 19-21,2018,Melbourne,Australia.

Related Societies: American Heart Association Dallas, USA, North America ; Cardiology Society Los Angeles, USA, North America; Emirates Cardiac Society Macau, Hong Kong ; Japanese Circulation Society, Japan; British Junior Cardiologists Association London, UK; Cardiac Society of Australia and New Zealand Sydney, Australia; World Society of Arrhythmias Beijing, China; Philippine Heart Association Manila, Philippines; Asian Society for Cardiovascular Surgery (ASCVS) Fukuoka, Japan, Asia ; The Pan-African Society of Cardiology (PASCAR) Algeria, Africa ; Iranian Heart Foundation Iran ; Emirates Cardiac Society Macau, Hong Kong ; Saudi Heart Association Riyadh, Saudi Arabia ; Gulf Heart Association Macau, Hong Kong ; Indonesian Heart Association, Indonesia.

Track 2: Clinical Cardiology

Clinical cardiology is the branch of internal medicine that deals with malfunctions and disorders related to heart in humans and animals. The field includes diagnosis and treatment of heart failure, congenital heart defects, coronary artery disease, valvular heart disease and electrophysiology. It is manly dependent on the circulatory system or circulatory process also called the cardiovascular system. In circulation process, Blood carries oxygen and nutrients from your heart to the rest of the body through a complex network of arteries, arterioles, and capillaries whereas the deoxygenated blood is carried back to your heart through venules and veins. The physicians who are specialized in this field are called cardiologists. The Cardiothoracic surgeons or Cardiac surgeons are the ones who are specialized in cardiology from general surgery. Clinical Cardiology plays a major role in coordination of research in medical diagnosis, cardiovascular medicine and cardiovascular surgery.

Track 3: Heart Diseases

Heart diseases are also called as cardiovascular diseases which in turn include the conditions that affect the mechanism, function or structure of heart. Heart diseases are may be classified into congenital and acquired heart diseases. Most of the cases, it is considered to be an acquired heart diseases. Common cardiovascular diseases are called coronary artery diseases such as angina and myocardial infarction.

Track 4: Women & Heart Diseases

Studies have been revealed that every 1 out of 3 women in U.S are exposed to a heart disease that is approximately 1 woman per minute. It is also stated that women with diabetes have higher CVD mortality rates than men with diabetes. Women who are all taking g physical activity for less than 2 hours are considered to have more risk for coronary artery disease. Coronary microvascular disease (MVD) and broken heart syndrome are the two heart diseases that affect women more than men. Wherein, MVD is caused due to tiny arteries and Broken Heart syndrome is caused due to emotional stress leading muscle failure. Go Red for Women is a major international awareness campaign dedicated to the prevention, diagnosis and control of heart disease and stroke in women. Coronary microvascular disease (MVD).

Track 5: Hypertension

Hypertension, also known as high blood pressure is a long term medical condition in which the blood pressure in the arteries is frequently elevated. High blood pressure usually does not cause symptoms. Long term high blood pressure is a main risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss, and chronic kidney disease. It is classified into primary high blood pressure or secondary high blood pressure. Due to nonspecific lifestyle and genetic factors about 90–95% of cases are primary hypertension. Lifestyle factors that increase the risk constitute excess salt, excess body weight, smoking, and alcohol. The rest 5–10% cases are due to secondary hypertension, which constitutes chronic kidney disease, narrowing of the kidney arteries, a hormone-related disorder, or the use of birth control pills. Blood pressure is calculated by two measurements, the systolic and diastolic blood pressures, these are the maximum and minimum pressures, respectively. At rest, normal blood pressure is within the range of 100–140 mm of mercury (mmHg) during systole and 60–90 mmHg diastoles.

Track 6: Echocardiography

Echocardiography is referred to as cardiac echo produced by the ultrasound waves which in turn create the images of the heart. This is a type of ultrasound test that uses high-pitched sound waves that are sent through a device called a transducer. The device receives the echoes of the sound waves as they bound with the different parts of your heart. These echoes tend to create moving pictures of your heart that can be seen on a video screen. It helps to detect cardiomyopathies, such as hypertrophic cardiomyopathy, dilated cardiomyopathy, and many others.

Track 7: Diabetes&Heart

Diabetes Heart Disease (DHD) is defined as the heart disease which occurs in individuals who are having high level of carbohydrates in blood (Diabetes).It has been observed that cardiovascular disease is the leading cause of mortality for people with diabetes. People with diabetes are tending to have hypertension, abnormal blood lipids and obesity which are all considered as risk factors for cardiovascular disease. For the past two decades several advances in treating heart disease have improved the chances of surviving a heart attack or stroke. However, the incidence of diabetes steadily increases are proportional to the number of new cases of heart disease and cardiovascular complications.

Track 8: Cardio-Oncology

Cardio-Oncology is defined as the interdisciplinary field of medicine in which the clinical alterations of cardiovascular system are studied during the different methods of treatments of cancer. It aids in studying the heart conditions in patients who have been treated for cancer. The ultimate aim of Cardio oncology is to find a balance between oncologic efficacy and reducing adverse cardiovascular effects. Age, obesity, use of tobacco, intake of certain types of cancer drugs or radiation treatment to the chest is considered as the risk factors by cardiologists. . Other reasons may be the consequences of radio- and chemo-therapy in long-term survivors of malignancy. All patients who are being considered for chemotherapy, especially those who have prior history of cardiac disease should undergo detailed cardiovascular evaluation to optimize the treatment. Serial examination of left ventricular systolic function and cardiac biomarkers might also be considered in the selected populations of patient. Malignancy can also occur during long-term follow-up after coronary artery bypass graft (CABG). Cardio-oncology studies helps oncologists in early treatment by closely watching the heart of their patients to protect them.

Track 9: Pediatric & Geriatric Cardiology

Pediatric cardiology is the branch of cardiology which involves in the treatment of childhood disorder includes both the heart and lungs problems. A person who had received extensive training in diagnosing the pediatric cardiopulmonary disease are called pediatric cardiologist. Pediatric cardiology aims in preventing both the congenital and acquired human heart diseases in children, infants and adolescents. It offers a new platform to educate the next generation physician in pediatric cardiology. Cardiac catheterization technique is also involved in pediatric cardiology.

Geriatric Cardiology means cardiovascular care of patients 65 years of age or older. The geriatric population is further broken down into elderly (between ages 75 and 84 years) and very elderly (85 years of age or older), with numbers reaching 40 million and 13 million people, respectively. Vascular disorders such as atherosclerosis and peripheral arterial disease cause significant morbidity and mortality in aged people.

Track 10: Interventional Cardiology

Interventional cardiology –is the branch of cardiology that handles with the specific Cather based techniques to various structural heart diseases, non-surgical procedures for treating cardiovascular diseases. Often, to avoid the need for surgery a thin, flexible tube called catheter is used to repair damaged vessels or other heart structures diseases. In addition, for an acute myocardial infarction the procedure involved in interventional cardiology for acts as a best standard of care. It involves in elimination of clots from coronary arteries and implementation of stents and balloons through a small hole made in a major artery. Coronary intervention will remain the dominant procedure for the interventional cardiologist, which leads to the development of new procedures in coming decade in proportional to the population growth. It is expected that interventional cardiology craves a new attention in the growth of valvular heart disease intervention.

Track 11: Nuclear Cardiology

Nuclear cardiology “Non-invasive diagnosing studies involved in cardiology to analyze myocardial blood flow, to determine the pumping mechanism of the heart and to visualize the size and location of heart after the consequences of heart attack or any heart diseases”. Different Imaging techniques are used in nuclear cardiology to perform the assessment in a heart patient. Among those, the myocardial perfusion imaging is the commonly used one.

Track 12: Sports Cardiology

Sports Cardiology achieves heart screenings that detect potentially serious cardiovascular issues in young athletes. Sudden cardiac arrest (SCA) is the major reason of death in exercising young athletes, and is most commonly set off by problems as structural heart disorders or electrical circuitry issues which are not commonly found during routine physical examinations. Most of the conditions that cause sudden cardiac death in young athletes are evaluated by an electrocardiogram (ECG or EKG), a non-invasive test which calculates the electrical activity of the heart.

Track 13: Cardiac Surgery

Cardiovascular surgery is also known as thoracic surgery which is operated on the heart or great vessels by cardiac surgeons and it is the field of medicine involved in surgical treatment of organs inside the thorax. There are five types of cardiac surgery 1) Open heart surgery 2) Modern beating-heart surgery 3) Heart transplant 4) Coronary artery bypass grafting 5) Minimally invasive surgery and surgeries are done to treat complexity of ischemic heart disease, correct congenital heart disease, or treat valvular heart disease from various causes including endocarditis, rheumatic heart disease and atherosclerosis and advancement of cardiac surgery and cardiopulmonary bypass techniques has greatly reduced the mortality rates of these procedures. The surgery requires postoperative care to avoid complications. Laceration care is needed to avoid infection and minimize scarring. Swelling and loss of appetite are common, as mentioned Coronary artery bypass grafting (CABG) is the most common type of heart surgery. CABG improves blood flow to the heart.

Track 14: Cardiac Nursing

Cardiac nursing is a nursing specialty that works with patients who suffer from various conditions of the cardiovascular system. Cardiac nurses help treat conditions such as unstable angina, cardiomyopathy, coronary artery disease, congestive heart failure, myocardial infarction and cardiac dysrhythmia under the direction of a cardiologist. Cardiac nurses perform postoperative care on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health assessments. Cardiac nurses work in many different environments, including coronary care units (CCU), cardiac catheterization, intensive care units (ICU), operating theatres, cardiac rehabilitation centers, clinical research, cardiac surgery wards, cardiovascular intensive care units (CVICU), and cardiac medical wards.

Track 15: Cardiac Regeneration

Cardiac Regeneration: “Repairing the Cardiac Cells, tissues and its function which is damaged by the heart disease is known as cardiac regeneration. Reparative stem cells have the capability to restore function to damaged tissue by renewing cell growth in cardiac cells. A decade ago Stem cell based therapies as considered as the clinical trials for cardiac regeneration. Now, bone marrow derived stem cells (BMCs), adult stem cells from adipose or cardiac tissue are used in current clinical studies with inconsistent results but the outcomes in terms of feasibility and safety are encouraging in cardiac regeneration. In future, myocardial regeneration, transplantation of stem or progenitor cells, stimulation of endogenous cardiac repair by pharmacological agents and Tissue engineering will play a major role in cardiac regeneration.

Track 16: Case Reports On Cardiology

A case report on Cardiology gives an appropriate convention for all cardiologists by rendering their important clinical cases of late occurrence. Studying from medical cases provides valuable experience for clinicians, students and paramedical staff -members. Rare medical reports and conditions discovered through the latest methods of examination are energized. Moreover, studying diagnostic methods from medical cases and the interpretation of symptoms is significant to train and burgeon the thought processes which are being used in the clinical field.

Overview of the global interventional cardiology market

The interventional cardiology and peripheral vascular devices market is expected to reach $26.72 Billion by 2019 from $18.73 Billion in 2014, at a CAGR of 7.4%. Major factors driving the growth of this market include rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements. Moreover, emerging economies such as India and China present an array of opportunities for the growth of this market. However, product failures and barriers to entry for small players are expected to restrain the growth of this market.

The growing demand for minimally invasive (MI) procedures will drive the growth prospects for the global interventional cardiology market in the forthcoming years. Some of the major factors responsible for the growing preference for MI includes faster recovery, less pain, fewer post-surgery infections, reduced hospital stays, minimized incision marks, controlled bleeding, and minimal complications and high accuracy. Also, MI artery stenting enhances the surgical precision by providing a 3D view of the patient and allowing the manipulation of small surgical tools for the placement of stents in the individual's body. As a result, 3D-MRI techniques for improved imaging has increased the popularity of MRI procedures, which will eventually increase the demand for cardiac surgeries.

The growing popularity of hybrid procedures will drive the growth prospects for the global industrial castings market over the next four years. According to the industry research report, one of the major factors responsible for the growing preference for hybrid procedures is their ability to eradicate plaque entirely from the blood vessels and offer qualitative results to patients.

Global Interventional Cardiology Market 2017 - Forecast to 2023: Stents Market Dominated the $46.12 Billion Products MarketA

The interventional cardiology global market is expected to grow at a CAGR of high single digit CAGR to reach $46,124.1 million by 2023.

Among the Interventional cardiology products, the stents market dominated the products market by occupying a largest share. At the same time, Transcatheter heart pump market is the fastest growing segment projected to grow at a high double digit CAGR. In applications, Coronary Interventions is the largest segment and Structural Heart is the fastest growing segment with the strong CAGR.

The APAC region is projected to be the fastest growing region suggesting an opportunities for growth and likely to get attention of new investors in the interventional cardiology market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.

Why Hong Kong:

Hong Kong is a special administrative region of the People's Republic of China. It is the world’s freest and eighth largest economy. Hong Kong has no tariffs on imported goods and levies excise duty only on hydrocarbon oil, hard alcohol, tobacco, and methyl alcohol. It is the second largest recipient as well as supplier of FDI in the world. The country was ranked fifth easiest country to do business, by Doing Business.

Hong Kong acts as a bridgehead to China’s production, has an efficient banking system, favorable tax measures, excellent infrastructure, strong government, light legislations, well-educated skilled workers, and freedom of information. In 2003, Hong Kong SAR government launched CIES facilitated entry for foreign investors through investment into permissible assets, without the need to establish or join a business. Foreign companies can be set up freely, register their brands and the director of the company need not be a citizen or resident of Hong Kong. The only drawbacks are the high cost of living, elevated salaries, dependence on the financial sector, and exposure to global market risks.

With the presence of all major firms in the small region of Hong Kong, conducting business becomes very easy. Hong Kong is deemed to be the safest place to invest in the South-East Asia region.

Cardiologists 2017

In the presence of cardiologists, professional researchers, scientists, practitioners and medical students involved in the development of high-quality education in all aspects of clinical skills, Conference Series 18^th Annual Cardiologists Conference was held during June 19-21, 2017 in Paris, France.

Conference Series Group played host to a diverse panel of key members of the Cardiologists 2017 community from research lab, industry, academia and financial investment practices, discussing the future of Cardiology and Cardiovascular specialties. This event was really aimed for examining where the real cardio-logical specialties are going to the future and purpose of the event was to provide an opportunity for cross-fertilization of ideas and development of ideas, in the field of Cardiology.

Focusing on Cardiology, Pediatric Cardiology, Heart Diseases, Echocardiography, Interventional Cardiology, Heart and Blood Vessel Surgeries, Cardiac Nursing, Diabetes, Cardiac Surgeries, Case Reports on Cardiology and the Heart and Heart Failure as well, the three days of discussions enabled professionals to gain an insight into the current innovations and opened up networking opportunities.

Cardiologists 2017 Organizing Committee would like to thank the Moderators of the conference – Dr. Fabiola B Sozzi, University Hospital Policlinico of Milan, Italy, Dr. Marco Picichè, San Camillo-Forlanini Hospital, Italy and Dr. Guy Hugues Fontaine, Universite Pierre et Marie Curie & La Salpêtrière Hospital, France who contributed a lot for the smooth functioning of this event.

We would also like to thank our YRF Judge - Dr. Guy Hugues Fontaine, Universite Pierre et Marie Curie & La Salpêtrière Hospital, France and Poster Judge – Dr. Jean-Pierre Usdin, American Hospital of Paris, France.

The conference was embarked with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by Honourable Guests and members of the Keynote forum. The highlights of the meeting were the eponymous lectures, delivered by:

Guy Hugues Fontaine, Universite Pierre et Marie Curie & La Salpêtrière Hospital, France

William E Feeman Jr., Wood County Hospital, USA

John J Wang, Philips Healthcare, USA & B Milan Horacek Dalhousie University, Canada

Rachad M Shoucri, Royal Military College of Canada, Canada

Jean-Pierre Usdin, American Hospital of Paris, France

Robert Skalik, WrocÅ‚aw Medical University & Leszno Medical Centre Ventriculus, Poland

Daniel A Lichtenstein, Ambroise-Pare Hospital, France

Aris Lacis, Children's Clinical University Hospital, Latvia

Fabiola B Sozzi, University Hospital Policlinico of Milan, Italy

Marco Picichè, San Camillo-Forlanini Hospital, Italy

Philippe Chevalier, Louis Pradel Cardiology Hospital of Lyon, France

Galal Eldin Nagib El-kilany, Gulf Medical University, UAE

These talks were of great interest to the general cardiologists and were enormously informative.

Best Poster Award was given to - Dr. Amjed Eljaili, Betsi Cadwalader University Health Board, UK.

18^th Annual Cardiologists Conference was a great success with the support of international, multi-professional steering committee and coordinated by the Journal of Clinical & Experimental Cardiology, Journal of Cardiovascular Diseases & Diagnosis and Cardiovascular Pharmacology: Open Access. We are happy to announce our 25^th Annual Cardiologists Conference, which will be held during Sep 17-18,2018 Hong Kong

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	September 17-18,2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View